Login to Your Account

$15M in Series A Cash

Inviragen Risky, SingVax Less: They Marry in Vaccine Heaven

By Trista Morrison

Wednesday, October 7, 2009
Inviragen LCC and SingVax Pte Ltd. merged their preclinical vaccine pipelines and closed a $15 million Series A financing to tackle infectious diseases affecting emerging markets. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription